BGN Technologies, the technology-transfer company of Ben-Gurion University, has introduced a therapy for neurological disorders such as stroke and Alzheimer’s. Memantine and Losartan are combined to protect the blood-brain barrier from neurotoxic blood products.

https://www.israel21c.org/novel-combination-therapy-treats-neurological-disorders/